Publications by authors named "S Jalili"

Objective: Older adults have an increased risk of developing persistent cognitive complaints after mild traumatic brain injury (mTBI). Yet, studies exploring which factors protect older adults with mTBI from developing such complaints are rare. It has been suggested that one such factor may be cognitive reserve (CR), but it is unknown how CR influences cognition in this patient category.

View Article and Find Full Text PDF

Background: Individuals experiencing severe cases of Coronavirus Disease 2019 (COVID-19) exhibited elevated fibrinogen levels and decreased albumin levels, potentially linked to the presence of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) proteins. Consequently, our study endeavors to examine the impact of SARS-CoV-2 ORF9b on the expression of fibrinogen and albumin genes within the Hep-G2 cell line.

Methods: In this study, the Hep-G2 liver cell line was utilized alongside the plasmid pcDNA3.

View Article and Find Full Text PDF

Osteoarthritis (OA) presents a significant global health burden, necessitating innovative therapeutic strategies to address its multifaceted challenges. This study explores the potential of extract-loaded chitosan nanoparticles (CTECNPs) as a novel treatment modality for OA. The encapsulation of extract (CTE) within chitosan nanoparticles offers advantages such as enhanced bioavailability, sustained release kinetics, and targeted delivery to affected joints.

View Article and Find Full Text PDF

When subjected to injury, the spinal cord's inherent complexity poses significant challenges for effective healing. In this study, gelatin nanofibers loaded with Laurus nobilis extract were developed to serve as a delivery system for adipose-derived stem cells (ADSCs), aiming to explore its potential immunomodulatory effects in a rat model of spinal cord injury. Through a series of in vitro assessments including scanning electron microscopy imaging, cell viability, anti-inflammatory, cell adhesion, biodegradation, and hemocompatibility assays, the characteristics of the delivery system were thoroughly evaluated.

View Article and Find Full Text PDF
Article Synopsis
  • The study examines genetic mutations in myelodysplastic syndromes (MDS), focusing on SF3B1 and SRSF2, using multi-omics data to analyze their effects on patient outcomes.
  • It identifies seven factors from clinical, genetic, and transcriptomic data, highlighting a strong link between SF3B1 mutations and increased inflammation, which is paradoxically associated with better prognosis for certain patients.
  • SRSF2 mutations correlate with poor outcomes due to high levels of aging and malignant cells, while the expression of retrotransposons is identified as a risk factor, showcasing an advanced method for assessing MDS risk beyond traditional scoring systems.
View Article and Find Full Text PDF